International Drug & Explosives Detection Firm IDenta Corp. Reports on Marketing Developments in India
JERUSALEM--(Marketwire - December 15, 2009) - IDenta Corp. (
This is the first release about IDenta's activities in India, one of the largest markets in Asia and in the world.
India is becoming a major target market for IDenta's different kits, due to the huge security and drug problems in the region.
IDenta Corp. CEO Yaacov Shoham today released this statement concerning developments in India.
Mr. Shoham stated, "In the past year (2009) through our representative in India, Technomaxx, a company from New Delhi, [ www.technomaxx.com ], IDenta has been able to penetrate some large federal agencies and some local police departments and we presented our different products (drug detectors, explosive detectors and precursors). It was our first year in the India market, and we look forward to developing a strong market in India starting with the year 2010."
During 2009, IDenta Corp. has already received and delivered several orders from India, so far a total of several tens of thousands of kits. It is only the beginning of marketing and sales of this huge market.
In 2009, IDenta's CEO and Chief Scientist have participated at two All India Forensic Science Conferences (in January and November 2009).
Those conferences have been attended by many of the decision makers, scientists and kit users of the different forensic departments in India. During the conferences, IDenta representatives have also been able to learn about the special needs of the India forensics agencies, and as a result of the special needs, IDenta is already making some changes with one of the IDenta Alert explosive detectors. In IDenta's opinion, the change in the kit will make it very "attractive" in the India forensic market.
ABOUT IDENTA
Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
Information concerning IDenta's entire product line may be found at [ www.IDenta.biz ]
DISCLAIMER
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, [ fpi@drugsdetector.com ], [ www.identa.biz ].
For information about the Accutest® -- IDenta products in the US, please contact: Mr. Eyal Golan, COO, JANT PHARMACAL CORPORATION, 16255 Ventura Blvd. #505, Encino, CA 91436, Toll Free: 800-676-5565, 661-478-0582 (mobile), [ golan@accutest.net ], [ www.accutestidenta.net ].